University of Paris-Sorbonne-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2021

  1. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet Respiratory Medicine, Vol. 9, Núm. 5, pp. 522-532